Minqing Wu

850 total citations
20 papers, 727 citations indexed

About

Minqing Wu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Minqing Wu has authored 20 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Minqing Wu's work include MicroRNA in disease regulation (6 papers), PARP inhibition in cancer therapy (4 papers) and Circular RNAs in diseases (3 papers). Minqing Wu is often cited by papers focused on MicroRNA in disease regulation (6 papers), PARP inhibition in cancer therapy (4 papers) and Circular RNAs in diseases (3 papers). Minqing Wu collaborates with scholars based in China, United States and Australia. Minqing Wu's co-authors include Xiaoming Xie, Hailin Tang, Xinhua Xie, Laisheng Li, Jiaoli Guo, Lu Yang, Yanan Kong, Weidong Wei, Jie Gao and Xiaoping Liu and has published in prestigious journals such as PLoS ONE, Cancer Letters and Molecular Therapy.

In The Last Decade

Minqing Wu

18 papers receiving 719 citations

Peers

Countries citing papers authored by Minqing Wu

Since Specialization

Citations

This map shows the geographic impact of Minqing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minqing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minqing Wu more than expected).

Fields of papers citing papers by Minqing Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minqing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minqing Wu. The network helps show where Minqing Wu may publish in the future.

Co-authorship network of co-authors of Minqing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Minqing Wu. A scholar is included among the top collaborators of Minqing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minqing Wu. Minqing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Potential predictive value of CD8A and PGF protein expression in gastric cancer patients treated with neoadjuvant immunotherapy 2025 ·BMC Cancer ·Chengjuan Zhang, Tingjie Wang, Jing Yuan, Tuo Wang, Bin Ma, Benling Xu, Ruihua Bai, (unknown), Xiaojie Zhang, Minqing Wu, Ting Lei, Wenhao Xu, (unknown), Ning Li	0
2	A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer 2022 ·Breast Cancer ·Anli Yang, Minqing Wu, (unknown), Lijuan Zhang, Mingyue Li, Peijun Wei, (unknown), Weikai Xiao, Xin An	9
3	Key Issue Analysis on 5G Inter-networks Roaming 2022 ·(unknown), Zhenhua Lv, Xuexin Li, (unknown), Qingyang Wang, Minqing Wu	0
4	Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse Gastric Cancer 2022 ·JAMA Network Open ·Zexian Liu, Xiaolong Zhang, Qi Zhao, (unknown), Hui Sheng, Caiyun He, Yuting Sun, (unknown), Minqing Wu, Zhixiang Zuo, Wei Wang, (unknown), Feng‐Hua Wang, Yuhong Li, Rui‐Hua Xu, Miao‐Zhen Qiu	8
5	Estimation model of canopy stratification porosity based on morphological characteristics: A case study of cotton 2020 ·Biosystems Engineering ·Xinghua Liu, (unknown), (unknown), Yang Li, Jin Yuan, (unknown), Huan Li, Minqing Wu	14
6	Nrdp1 expression to predict clinical outcome and efficacy of adjuvant anthracyclines-based chemotherapy in breast cancer: A retrospective study 2015 ·Cancer Biomarkers ·Shiping Jiao, Wenjie Liu, Minqing Wu, Cheng‐Yuan Peng, Hailin Tang, Xiaoming Xie	5
7	miR-185 Suppresses Tumor Proliferation by Directly Targeting E2F6 and DNMT1 and Indirectly Upregulating BRCA1 in Triple-Negative Breast Cancer 2014 ·Molecular Cancer Therapeutics ·Hailin Tang, Peng Liu, Lu Yang, Xinhua Xie, Ye Feng, Minqing Wu, Xiaoping Liu, Bo Chen, Lijuan Zhang, Xiaoming Xie	101
8	miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer 2014 ·Cancer Letters ·Peng Liu, Hailin Tang, Bo Chen, Zhimin He, Min Deng, Minqing Wu, Xiaoping Liu, Lu Yang, Feng Ye, Xiaoming Xie	90
9	Up-regulation and worse prognostic marker of cytoplasmic TARBP2 expression in obstinate breast cancer 2014 ·Medical Oncology ·Xiaoti Lin, Minqing Wu, Peng Liu, Fengqin Wei, Laisheng Li, Hailin Tang, Xinhua Xie, Xiaoping Liu, Lu Yang, Xiaoming Xie	11
10	Development of PEA-15 using a potent non-viral vector for therapeutic application in breast cancer 2014 ·Cancer Letters ·Xinhua Xie, Hailin Tang, Peng Liu, Yanan Kong, Minqing Wu, Xiangsheng Xiao, Lu Yang, Jie Gao, Weidong Wei, Jangsoon Lee, Chandra Bartholomeusz, Naoto T. Ueno, Xiaoming Xie	9
11	miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family 2014 ·Journal of Translational Medicine ·Ye Feng, Hailin Tang, Qing Liu, Xinhua Xie, Minqing Wu, Xiaoping Liu, Bo Chen, Xiaoming Xie	67
12	BikDDA, a Mutant of Bik with Longer Half-Life Expression Protein, Can Be a Novel Therapeutic Gene for Triple-Negative Breast Cancer 2014 ·PLoS ONE ·Shiping Jiao, Minqing Wu, Feng Ye, Hailin Tang, Xinhua Xie, Xiaoming Xie, (unknown), (unknown)	7
13	MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1 2013 ·PLoS ONE ·Jie Gao, Laisheng Li, Minqing Wu, Min Liu, Xinhua Xie, Jiaoli Guo, Hailin Tang, Xiaoming Xie	107
14	Synergistic effects of curcumin with emodin against the proliferation and invasion of breast cancer cells through upregulation of miR-34a 2013 ·Molecular and Cellular Biochemistry ·Jiaoli Guo, (unknown), (unknown), Xinhua Xie, Laisheng Li, Hailin Tang, Minqing Wu, Yanan Kong, Lu Yang, Jie Gao, Peng Liu, Weidong Wei, Xiaoming Xie	94
15	Efficient systemic DNA delivery to the tumor by self-assembled nanoparticle 2013 ·Journal of Nanoparticle Research ·Hailin Tang, Xinhua Xie, Jiaoli Guo, Weidong Wei, Minqing Wu, Peng Liu, Yanan Kong, Lu Yang, Mien‐Chie Hung, Xiaoming Xie	2
16	Correction: MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1 2013 ·PLoS ONE ·Jie Gao, Laisheng Li, Minqing Wu, Min Liu, Xinhua Xie, Jiaoli Guo, Hailin Tang, Xiaoming Xie	17
17	Absence of evidence for epidermal growth factor receptor and human homolog of the Kirsten rat sarcoma-2 virus oncogene mutations in breast cancer 2012 ·Cancer Epidemiology ·Ning Lv, Suxia Lin, Zeming Xie, Jun Tang, (unknown), Minqing Wu, Xinhua Xie, (unknown), (unknown), Weidong Wei	4
18	Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer 2012 ·Medical Oncology ·Minqing Wu, Weidong Wei, Xiangsheng Xiao, Jiaoli Guo, Xinhua Xie, Laisheng Li, Yanan Kong, Ning Lv, Wei‐Hua Jia, Yin Zhang, Xiaoming Xie	72
19	Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion 2012 ·Molecular Therapy ·Laisheng Li, Xinhua Xie, (unknown), Min Liu, Shaoyan Xi, Jiaoli Guo, Yanan Kong, Minqing Wu, Jie Gao, Zeming Xie, Jun Tang, Xi Wang, Weidong Wei, (unknown), Mien‐Chie Hung, Xiaoming Xie	88
20	Targeted Expression of BikDD Eliminates Breast Cancer with Virtually No Toxicity in Noninvasive Imaging Models 2012 ·Molecular Cancer Therapeutics ·Xinhua Xie, Laisheng Li, Xiangsheng Xiao, Jiaoli Guo, Yanan Kong, Minqing Wu, Wanli Liu, Guoquan Gao, Jennifer L. Hsu, Weidong Wei, Mien‐Chie Hung, Xiaoming Xie	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact